SENSEX NIFTY

Q4

Jul 31, 2014 at 18:08 | Source: CNBC-TV18
Asset quality will also be closely watched as it deteriorated in previous quarter. Slippages and restructured loans continued to remain elevated. The restructured pipeline was Rs 1,700 crore at the end of March 2014 with gross non-performing assets (GNPA) guidance at 3.75 percent as against 4.08 percent in Q4FY14.
Jul 31, 2014 at 16:45 | Source: PTI
Symphony's net sales in the quarter under review stood at Rs 150.63 crore, up 35.49 percent as against Rs 111.17 crore in the same period last year.
Jul 31, 2014 at 13:07 | Source: Moneycontrol.com
Quarterly revenues were up 1 percent sequentially to Rs 8424 crore, compared to the poll estimate of Rs 84448.2 crore. Earnings before interest and taxes (EBIT) declined 1 percent to operating margin declined 50 basis points sequentially to 24.2 percent, but was ahead of the poll estimate of 23.6 percent to Rs 2038 crore.
Jul 31, 2014 at 12:40 | Source: CNBC-TV18
Margins for Excel Crop Care's first quarter stood at 15 percent versus 11.5 percent Y-o-Y and the net profit was up 68 percent at Rs 33crore versus Rs 19.5 crore Y-o-Y.
Jul 31, 2014 at 08:52 | Source: Moneycontrol.com
Operating margin declined 50 basis points sequentially to 24.2 percent, but was ahead of the poll estimate of 23.6 percent
Jul 30, 2014 at 18:46 | Source: CNBC-TV18
Operating profit may slip 24 percent on yearly basis to Rs 695 crore and margin may decline significantly to 32.3 percent from 39.5 percent during the same period but that may improve compared to 18 percent margin in Q4FY14 that was impacted by one-off pertaining to Aman Resorts transaction.
Jul 30, 2014 at 18:28 | Source: CNBC-TV18
Rupee revenue is expected to increase 1.2 percent quarter-on-quarter to Rs 8,448.2 crore while dollar revenue may grow 3.76 percent to USD 1412.4 million in the quarter ended June 2014 aided by constant currency growth of 3.2-3.33 percent.
Jul 30, 2014 at 17:38 | Source: CNBC-TV18
Asset quality may be improved in the quarter ended June 2014 as the management (after Q4FY14 earnings) had said FY14 was the peak of addition to restructured assets and the company could see less stress on asset quality in FY15.
Jul 24, 2014 at 14:58 | Source: Moneycontrol.com
TVS said it got good response for its products - Apache, Jupiter and Wego. "2014-15 will be a breakthrough year for company," it added. It expects to launch new Scooty in August and one new motorcycle each in Q3 and Q4.
Jul 24, 2014 at 11:41 | Source: CNBC-TV18
Revenue is seen going up by 15 percent on yearly basis to Rs 804 crore, which is similar to revenue growth in Q4FY14. Operating profit (EBITDA) may grow 21 percent at Rs 184.3 crore compared to Rs 152 crore in same quarter last fiscal. Margin may expand 120 basis points Y-o-Y to 22.9 percent in the quarter gone by, aided by lower R&D spend.
Messages on Q4 »

bvijaaaa576

New Member

0 Follower

Aurobindo Pharm  

golden chance to buy at this level. Q4 results are very strong . Target before results 1000.

3.06 PM Jul 8th

shmarketgen
ius

Platinum Member

364 Followers

Hinduja Global  

Q4 was not upto the mark,but for full FY14,HGS has managed to increase its revenues by a healthy 26%.This was accompanied by a near 90% rise in EPS.I see no reason,why 20-25% growth should be a problem.The Phillipines business will also pick up this year & beyond.

11.21 AM Jul 8th

lcm

New Member

4 Followers

Neo Corp Inter  

Q4 base was 9,now Q1 base is 15 next base at 26 plus.buy and keep patience.

10.03 AM Jul 8th

niru to help

Platinum Member

368 Followers

Visesh Infotech  

to declare Q4 results which i don`t know what they have given. Hence, it will not get delisted. And my target of 3 months is between Rs 2-3. It can be more than that.

11.59 PM Jul 7th

follower

Gold Member

17 Followers

Astec Life  

Dear unseenvalue, what kind of growth prospects does the Company management envisage in next 6-12 months. The growth in latest Q4 2014 was not very good. Though operating margin is comparable to Industry players like Dhanuka etc, the return on net worth / ROCE is on lower side. The Company has

11.48 PM Jul 7th

setu74

Silver Member

2 Followers

Alembic Pharmaceuticals  

quarterly result will be soft post Q4 dumping. Performance will improve over Q2 and Q3. Sell at 305 and buy at 285 post results

2.48 PM Jul 7th

follower

Gold Member

17 Followers

Genus Power  

margin (OPM) however, dipped in the last (Q4 of FY 2015) quarter from 14.3% to 8.7%. They are one of the prominent players in the electrical metering and allied equipment segment.Please share if you have any information. warm regards!

1.30 PM Jul 7th

follower

Gold Member

17 Followers

Asahi Songwon  

.4 Q4 2014 Vinati: 22.2 / 23.3 RONW: Aarti: 22.1; Vinati: 32.1 Disc: I hold Asahi Songwon. warm regards!

8.50 PM Jul 6th

kanakbhai

Gold Member

42 Followers

RS Software  

and visibility of multiyear earning and also increasing dividend year after year.The answer to the second question is the RS Software has been unfairly treated by the market over it`s peers even after Q3/Q4 2014 results.Here is the real catch,when such a unfair valuation is given by market, means it is made

8.18 PM Jul 5th

akkirathore

Silver Member

2 Followers

PC Jeweller  

after q4 results. 96-105-92-120 10.35 AM Mar 22nd

9.46 PM Jul 4th

News across the web »
Jul 24, 2014 at 13:44 | Source: FirstPost
Jun 13, 2014 at 11:45 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.